Nation State APT Groups Targeting Companies Involved in COVID-19 Research and Vaccine Development

HIPAA Journal

Steve Alder

Advanced Persistent Threat (APT) groups in Russia and North Korea are targeting companies involved in research into COVID-19 and vaccine development, according to Microsoft. Six large pharmaceutical firms and a clinical research company are known to have been targeted by three APT groups who are attempting to gain access to research and vaccine data.

The cyberattacks have been on “pharmaceutical companies in Canada, France, India, South Korea and the United States,” according to Microsoft and three APT groups are known to be conducting attacks – the Russian APT group Strontium (aka Fancy Bear/APT28) and two APT groups with links to North Korea – The Lazarus Group (aka Zinc) and Cerium. Additionally, in the summer of 2020, warnings were issued by several government agencies about attacks on COVID-19 research firms by another Russian APT group, Cozy Bear (aka APT29).

The targeted organizations have...

Get the Morning Update

Thanks for subscribing!